India, Jan. 15 -- Wockhardt, once ranked among India's top pharmaceutical companies, has delivered a stunning revival. After a brutal near 93 percent collapse in its stock price over a decade, the company has surprised investors with a sharp rebound, soaring over 861 percent in the past two years, marking one of the most dramatic turnarounds in the sector. What triggered this remarkable turnaround?

Wockhardt Ltd, with a market capitalization of Rs. 22,700.16 crore, closed at Rs. 1,397 per equity share, up by 0.68 percent from its previous day's close price of Rs. 1,387.60 per equity share.

Wockhardt Limited is a Mumbai-based pharmaceutical and biotech company founded in 1967, operating across India, the US, Europe, and other global mark...